Self-administration of a novel subcutaneous bradykinin b(2) receptor antagonist, icatibant, as an effective treatment option in patients with hereditary angioedema

類似資料

• Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema
  著者:: Cicardi, M., 等
  出版事項: (2010)
• Safety and efficacy of icatibant self-administration for acute hereditary angioedema
  著者:: Boccon-Gibod, I, 等
  出版事項: (2012)
• 164 Treatment of Acquired Angioedema with the Bradykinin Receptor Antagonist Icatibant
  著者:: Siani, Maria Concetta, 等
  出版事項: (2012)
• Early presentation of clinical hereditary angioedema symptoms in an infant
  著者:: Pham, Hoang, 等
  出版事項: (2014)
• Social costs of icatibant self-administration vs. health professional-administration in the treatment of hereditary angioedema in Spain
  著者:: Blasco, Antonio J, 等
  出版事項: (2013)